<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb1450">
 <element-citation publication-type="journal" id="rf1430">
  <person-group person-group-type="author">
   <name>
    <surname>Talavera Pons</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Boyer</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lamblin</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Chennell</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Ch√¢tenet</surname>
    <given-names>F.-T.</given-names>
   </name>
   <name>
    <surname>Nicolas</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Sautou</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Abergel</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>Managing drug-drug interactions with new direct-acting antiviral agents in chronic hepatitis C</article-title>
  <source>Br. J. Clin. Pharmacol.</source>
  <volume>83</volume>
  <issue>2</issue>
  <year>2017</year>
  <fpage>269</fpage>
  <lpage>293</lpage>
  <pub-id pub-id-type="doi">10.1111/bcp.13095</pub-id>
  <pub-id pub-id-type="pmid">27530469</pub-id>
 </element-citation>
</ref>
